L-Proline Catalyzed Knoevenagel Condensation of Aldehydes with Active Methylene Compounds and Their Molecular Modeling Studies for Anti-SARS CoV-2 Potentials

Q4 Pharmacology, Toxicology and Pharmaceutics
B. Thorat, Dnyaneshwar T. Nagre, Pawan P Dhurandhar, Pratiksha K. Borase, Sweta Bavkar, Riddhi R. Kasar, Rohan D Narkar, M. Farooqui, Suraj N. Mali
{"title":"L-Proline Catalyzed Knoevenagel Condensation of Aldehydes with Active Methylene Compounds and Their Molecular Modeling Studies for Anti-SARS CoV-2 Potentials","authors":"B. Thorat, Dnyaneshwar T. Nagre, Pawan P Dhurandhar, Pratiksha K. Borase, Sweta Bavkar, Riddhi R. Kasar, Rohan D Narkar, M. Farooqui, Suraj N. Mali","doi":"10.2174/1573408018666220516104525","DOIUrl":null,"url":null,"abstract":"\n\nAn efficient one-pot synthesis of 2-alkylidene/arylidene derivatives was reported from active methylene compounds such as malononitrile/ethyl cyanoacetate/5-methyl-2,4-dihydro-3H-pyrazol-3-one and aldehydes in the presence of 10 mol% of L-proline (ethanol at room temperature).\n\n\n\nAll derivatives were obtained in good to excellent yields. The structures of the synthesized compounds were confirmed from their FTIR (Fourier-transform infrared spectroscopy), 1H-NMR (Proton nuclear magnetic resonance), and mass spectroscopy. The importance of these compounds is predicted from their SAR (structure-activity relationship) study. Moreover, these newer compounds were further docked into various therapeutic targets of the SARS-CoV-2 (severe acute respiratory syndrome–related coronavirus) virus.\n\n\n\nResults from our molecular docking suggested that these compounds have good inhibitory properties on the SARS- CoV-2 virus.\n\n\n\nL-proline (bifunctional organic catalyst) is found to be the best catalyst for the synthesis of different condensed products from active methylene compounds and aldehydes.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408018666220516104525","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1

Abstract

An efficient one-pot synthesis of 2-alkylidene/arylidene derivatives was reported from active methylene compounds such as malononitrile/ethyl cyanoacetate/5-methyl-2,4-dihydro-3H-pyrazol-3-one and aldehydes in the presence of 10 mol% of L-proline (ethanol at room temperature). All derivatives were obtained in good to excellent yields. The structures of the synthesized compounds were confirmed from their FTIR (Fourier-transform infrared spectroscopy), 1H-NMR (Proton nuclear magnetic resonance), and mass spectroscopy. The importance of these compounds is predicted from their SAR (structure-activity relationship) study. Moreover, these newer compounds were further docked into various therapeutic targets of the SARS-CoV-2 (severe acute respiratory syndrome–related coronavirus) virus. Results from our molecular docking suggested that these compounds have good inhibitory properties on the SARS- CoV-2 virus. L-proline (bifunctional organic catalyst) is found to be the best catalyst for the synthesis of different condensed products from active methylene compounds and aldehydes.
l -脯氨酸催化醛与活性亚甲基化合物的Knoevenagel缩合及其抗sars CoV-2电位的分子模型研究
以丙二腈/氰乙酸乙酯/5-甲基-2,4-二氢- 3h -吡唑-3-酮等活性亚甲基化合物和醛为原料,在10mol %的l-脯氨酸(乙醇)存在下,在室温下一锅法合成了2-烷基基/芳基衍生物。所有的衍生物都得到了很好的收率。通过FTIR(傅里叶变换红外光谱)、1H-NMR(质子核磁共振)和质谱对合成化合物的结构进行了确证。通过对这些化合物构效关系的研究,预测了它们的重要性。此外,这些新化合物进一步与SARS-CoV-2(严重急性呼吸综合征相关冠状病毒)病毒的各种治疗靶点对接。分子对接结果表明,这些化合物对SARS- CoV-2病毒具有良好的抑制作用。l -脯氨酸(双功能有机催化剂)是由活性亚甲基化合物和醛合成不同缩合产物的最佳催化剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Enzyme Inhibition
Current Enzyme Inhibition Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
1.30
自引率
0.00%
发文量
30
期刊介绍: Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信